English
Back
Download
Log in to access Online Inquiry
Back to the Top

Update

$Candel Therapeutics (CADL.US)$ Candel Therapeutics Closes Securities Offering to Raise $92 Million
MT Newswires· 4 mins ago
Candel Therapeutics (CADL) closed an offering of 12 million shares at $6 apiece and prefunded warrants to raise $92 million in gross proceed.
The warrants are for purchasing up to 3.33 million shares at $5.99 per prefunded warrant to purchase one share of common stock, the company said late Monday in a statement.
The sale includes 2 million shares sold following the full exercise of the underwriters' option.
Candel intends to use the net proceeds to continue the development of its product candidates, including preparing the submission of a biologics license application for CAN-2409 in prostate cancer.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
2
1
+0
6
Translate
Report
6685 Views
Comment
Sign in to post a comment
5099
Followers
24
Following
73K
Visitors
Follow
Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.